1e0f

Crystal structure of the human alpha-thrombin-haemadin complex: an exosite II-binding inhibitor

spinqualitylabelsall models 1e0f, resolution 3.10Å Show:Asymmetric Unit Biological Assembly Drag the structure with the mouse to rotate   Export Animated Image   Print3D Structural highlights 1e0f is a 9 chain structure with sequence from Homo sapiens and Haemadipsa sylvestris. Full crystallographic information is available from OCA. For a guided tour on the structure components use FirstGlance. Related: 3htc, 1dwb, 1dwc, 1dwd, 1dwe, 3hat, 1hgt, 2hgt, 1abi, 1abj, 1ad8, 1afe, 1aht, 1ai8, 1aix, 1bmm, 1bmn, 1dit, 1fpc, 1hag, 1hah, 1hai, 1hdt, 1hao, 1hap, 1hbt, 1hlt, 2hnt, 1hut, 4htc, 1hxe, 1hxf, 1ihs, 1iht, 1lhc, 1lhd, 1lhe, 1lhf, 1lhg, 1nrn, 1nro, 1nrp, 1nrq, 1nrr, 1nrs, 1ppb, 1thr, 1ths, 1tmb, 1tmt, 1tmu, 1tom, 1uma, 1uvs, 1uvt, 1uvu, 1bth, 1ay6, 1a4w, 1b5g, 1tbz, 1a46, 1a61, 1a2c, 1a3b, 1a3e, 1a5g, 1bhx, 1b7x, 1awf, 1awh, 1thp, 2thf, 1vr1, 7kme, 8kme, 1ba8, 1bbo Activity: Thrombin, with EC number 3.4.21.5 Resources: FirstGlance, OCA, PDBe, RCSB, PDBsum, ProSAT Disease [THRB_HUMAN] Defects in F2 are the cause of factor II deficiency (FA2D) [MIM:613679]. It is a very rare blood coagulation disorder characterized by mucocutaneous bleeding symptoms. The severity of the bleeding manifestations correlates with blood factor II levels. Genetic variations in F2 may be a cause of susceptibility to ischemic stroke (ISCHSTR) [MIM:601367]; also known as cerebrovascular accident or cerebral infarction. A stroke is an acute neurologic event leading to death of neural tissue of the brain and resulting in loss of motor, sensory and/or cognitive function. Ischemic strokes, resulting from vascular occlusion, is considered to be a highly complex disease consisting of a group of heterogeneous disorders with multiple genetic and environmental risk factors. Defects in F2 are the cause of thrombophilia due to thrombin defect (THPH1) [MIM:188050]. It is a multifactorial disorder of hemostasis characterized by abnormal platelet aggregation in response to various agents and recurrent thrombi formation. Note=A common genetic variation in the 3-prime untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increased risk of venous thrombosis. Defects in F2 are associated with susceptibility to pregnancy loss, recurrent, type 2 (RPRGL2) [MIM:614390]. A common complication of pregnancy, resulting in spontaneous abortion before the fetus has reached viability. The term includes all miscarriages from the time of conception until 24 weeks of gestation. Recurrent pregnancy loss is defined as 3 or more consecutive spontaneous abortions. Function [THRB_HUMAN] Thrombin, which cleaves bonds after Arg and Lys, converts fibrinogen to fibrin and activates factors V, VII, VIII, XIII, and, in complex with thrombomodulin, protein C. Functions in blood homeostasis, inflammation and wound healing. Evolutionary Conservation Check, as determined by ConSurfDB. You may read the explanation of the method and the full data available from ConSurf. Publication Abstract from PubMed The serine proteinase alpha-thrombin plays a pivotal role in the regulation of blood fluidity, and therefore constitutes a primary target in the treatment of various haemostatic disorders. Haemadin is a slow tight- binding thrombin inhibitor from the land-living leech Haemadipsa sylvestris. Here we present the 3.1 A crystal structure of the human alpha-thrombin- haemadin complex. The N-terminal segment of haemadin binds to the active site of thrombin, forming a parallel beta-strand with residues Ser214-Gly216 of the proteinase. This mode of binding is similar to that observed in another leech-derived inhibitor, hirudin. In contrast to hirudin, however, the markedly acidic C-terminal peptide of haemadin does not bind the fibrinogen-recognition exosite, but interacts with the heparin-binding exosite of thrombin. Thus, haemadin binds to thrombin according to a novel mechanism, despite an overall structural similarity with hirudin. Haemadin inhibits both free and thrombomodulin-bound alpha-thrombin, but not intermediate activation forms such as meizothrombin. This specific anticoagulant ability of haemadin makes it an ideal candidate for an antithrombotic agent, as well as a starting point for the design of novel antithrombotics. Crystal structure of the human alpha-thrombin-haemadin complex: an exosite II-binding inhibitor.,Richardson JL, Kroger B, Hoeffken W, Sadler JE, Pereira P, Huber R, Bode W, Fuentes-Prior P EMBO J. 2000 Nov 1;19(21):5650-60. PMID:11060016 From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See Also Thrombin

Proteopedia Page Contributors and Editors (what is this?)

OCA